Medizinische Universität Graz - Research portal
Theiler Georg |
** = Publications listed in SCI/SSCI/Pubmed
2017
Full paper/article (Journal)
** Schwetz, V; Librizzi, R; Trummer, C; Theiler, G; Stiegler, C; Pieber, TR; Obermayer-Pietsch, B; Pilz, S
Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas.
Metab Brain Dis. 2017; 32(1):155-161
Doi: 10.1007/s11011-016-9882-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Full paper/article (Journal)
** Rabensteiner, J; Theiler, G; Duettmann, W; Zollner-Schwetz, I; Hoenigl, M; Valentin, T; Leitner, E; Luxner, J; Grisold, A; Valentin, A; Neumeister, P; Krause, R
Detection of central venous catheter-related bloodstream infections in haematooncological patients.
Eur J Clin Invest. 2015; 45(8):824-832
Doi: 10.1111/eci.12477
Web of Science
PubMed
FullText
FullText_MUG
Short report/Letter
** Theiler, G; Schwetz, V; Gstettner, C; Wowra, B; Fürweger, C; Steiner, J; Schmidt, HH
CyberKnife radiosurgery leading to long-lasting complete remission in locally relapsed solitary plasmacytoma of the bone.
Ann Hematol. 2015; 94(7):1251-1253
Doi: 10.1007/s00277-015-2365-4
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
2014
Full paper/article (Journal)
** Hoenigl, M; Duettmann, W; Raggam, RB; Huber-Krassnitzer, B; Theiler, G; Seeber, K; Prueller, F; Zollner-Schwetz, I; Prattes, J; Wagner, J; Wölfler, A; Krause, R
Impact of structured personal on-site patient education on low posaconazole plasma concentrations in patients with haematological malignancies.
Int J Antimicrob Agents. 2014; 44(2):140-144
Doi: 10.1016/j.ijantimicag.2014.03.013
Web of Science
PubMed
FullText
FullText_MUG
** Pleyer, L; Burgstaller, S; Girschikofsky, M; Linkesch, W; Stauder, R; Pfeilstocker, M; Schreder, M; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Krippl, P; Geissler, D; Voskova, D; Schlick, K; Thaler, J; Machherndl-Spandl, S; Theiler, G; Eckmüllner, O; Greil, R
Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.
Ann Hematol. 2014; 93(11):1825-1838
Doi: 10.1007/s00277-014-2126-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pleyer, L; Germing, U; Sperr, WR; Linkesch, W; Burgstaller, S; Stauder, R; Girschikofsky, M; Schreder, M; Pfeilstocker, M; Lang, A; Sliwa, T; Geissler, D; Schlick, K; Placher-Sorko, G; Theiler, G; Thaler, J; Mitrovic, M; Neureiter, D; Valent, P; Greil, R
Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival.
Leuk Res. 2014; 38(4):475-483
Doi: 10.1016/j.leukres.2014.01.006
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Theiler, G; Quehenberger, F; Rainer, F; Neubauer, M; Stettin, M; Robier, C
The detection of calcium pyrophosphate crystals in the synovial fluid of patients with rheumatoid arthritis using the cytospin technique: prevalence and clinical correlation.
Rheumatol Int. 2014; 34(1):137-139
Doi: 10.1007/s00296-012-2608-9
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R
Azacitidine in Patients with Acute Myeloid Leukemia: Assessing the Potential Negative Impact of Elevated Baseline White Blood Cell Count on Outcome
BLOOD. 2014; 124(21):
Doi: 10.1182/blood.V124.21.2284.2284
Web of Science
FullText
FullText_MUG
** Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R
Azacitidine in Acute Myeloid Leukemia: Comparison of Patients with AML-MRF Vs AML-NOS Enrolled in the Austrian Azacitidine Registry
BLOOD. 2014; 124(21):
Web of Science
** Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R
Azacitidine in Patients with Relapsed/Refractory Acute Myeloid Leukemia : Retrospective Analysis of the Austrian Azacitidine Registry
BLOOD. 2014; 124(21):
Web of Science
** Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R
Azacitidine in Patients with Acute Myeloid Leukemia: Impact of Intermediate-Risk Vs High-Risk Cytogenetics on Patient Outcomes
BLOOD. 2014; 124(21):
Web of Science
** Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstoker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R
Azacitidine in Patients with Treatment-Related Acute Myeloid Leukemia: Retrospective Analysis of the Austrian Azacitidine Registry
BLOOD. 2014; 124(21):
Doi: 10.1182/blood.V124.21.3681.3681
Web of Science
FullText
FullText_MUG
2013
Abstract (Journal)
** Hoenigl, M; Duettmann, W; Huber-Krassnitzer, B; Theiler, G; Raggam, RB; Prueller, F; Zebisch, A; Neumeister, P; Wagner, J; Seeber, K; Wolfler, A; Krause, R;
Impact of structured on-site patient education on low posaconazole plasma concentrations.
MYCOSES. 2013; 56: 47-47.-6th Trends in Medical Mycology; OCT 11-14, 2013; Kopenhagen, DENMARK.
[Oral Communication]
Web of Science
** Robier, C; Amouzadeh-Ghadikolai, O; Bregant, C; Diez, J; Melinz, K; Theiler, G; Neubauer, M
The prevalence of erythroblasts in peripheral blood smears of patients with multiple sclerosis treated with natalizumab
ONKOLOGIE. . 2013; 36: 207-207.
[Oral Communication]
Web of Science
** Robier, C; Diez, J; Amouzadeh-Ghadikolai, O; Bregant, C; Melinz, K; Theiler, G; Quasthoff, S
Natalizumab induces erythroblastaemia in the majority of treated patients
MULT SCLER J. . 2013; 19(11):278-278.-29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS; OCT 02-05, 2013; Copenhagen, DENMARK.
[Poster]
Web of Science
** Robier, C; Egger, M; Wiesinger, K; Aigner, R; Theiler, G; Neubauer, M
Progression of light chain myeloma to secondary plasma cell leukemia associated with peripheral blood eosinophilia
ONKOLOGIE. 2013; 36: 156-156.
[Poster]
Web of Science
** Robier, C; Stettin, M; Theiler, G; Neubauer, M
Changes in platelet function and response to antiaggregatory treatment in patients with myeloproliferative neoplasms: A sequential study using multiple electrode aggregometry
ONKOLOGIE. . 2013; 36: 63-64.
[Poster]
Web of Science
2012
Full paper/article (Journal)
** Theiler, G; Langer-Wegscheider, B; Zollner-Schwetz, I; Valentin, T; Hönigl, M; Schnedl, W; Krause, R
Blurred vision and myopic shift in Puumala virus infections are independent of disease severity.
Clin Microbiol Infect. 2012; 18(10):E435-E437
Doi: 10.1111/j.1469-0691.2012.03997.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG